Suchergebnisse - "Kang, Connie"

PubPharm (211)

1

Ruxolitinib Cream 1.5% : A Review in Non-Segmental Vitiligo

enthalten in: Drugs | 2024

von Kang, C.

2

Correction : Lumasiran: A Review in Primary Hyperoxaluria Type 1

enthalten in: Drugs | 2024

von Kang, C.

ErratumFor: Drugs. 2024 Feb;84(2):219-226. - PMID 38252335

3

Sacituzumab Govitecan : A Review in Unresectable or Metastatic HR+/HER2- Breast Cancer

enthalten in: Targeted oncology | 2024

von Kang, C.

4

Danicopan : First Approval

enthalten in: Drugs | 2024

von Kang, C.

5

Impact of a Mock OSCE on Student Confidence in Applying the Pharmacists' Patient Care Process

enthalten in: Pharmacy (Basel, Switzerland) | 2024

von Cristobal, E. | Perkins, K. | Kang, C. | +1

6

Sacituzumab Govitecan: A Review in Unresectable or Metastatic HR+/HER2− Breast Cancer

enthalten in: Targeted oncology | 2024

von Kang, C.

7

Correction: Lumasiran: A Review in Primary Hyperoxaluria Type 1

enthalten in: Drugs | 2024

von Kang, C.

8

Sparsentan in immunoglobulin A nephropathy: a profile of its use

enthalten in: Drugs & therapy perspectives | 2024

von Heo, Y. | Kang, C.

9

Get on top of gout with a fresh look at treatment options

enthalten in: Drugs & therapy perspectives | 2024

von Fenton, C. | Kang, C.

10

Lumasiran : A Review in Primary Hyperoxaluria Type 1

enthalten in: Drugs | 2024

von Kang, C.

ErratumIn: Drugs. 2024 Mar 15;:. - PMID 38489088

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[22]